Skip to main content

Table 3 Clinical inquiries from DR-TB treatment sites and recommendations of the consilium

From: Multidisciplinary management of difficult-to-treat drug resistant tuberculosis: a review of cases presented to the national consilium in Uganda

  Count (%)
Clinical inquiries from DR-TB sites (N = 308)
Construction of treatment regimen 119 (38.6)
Management of adverse effect 74 (24.0)
Determination treatment duration 67 (21.8)
Validation of already prescribed regimen 30 (9.7)
Establishment of DR-TB diagnosis 17 (5.5)
Unknown 1 (0.3)
Recommendations of consilium (N = 471)
Construction of initial DR-TB regimen 102 (21.7)
Observation while on current regimen 78 (16.6)
Adherence counselling 66 (14.0)
Dose adjustment 36 (7.6)
Further diagnostic work up 35 (7.4)
Further clinical evaluation by specialist 32 (6.8)
Substitution of single agent in the regimen 30 (6.4)
Change of regimen (substituting 2 or more agents) 25 (5.3)
Adjunct medication 23 (4.9)
Withholding a single agent without substituting it 15 (3.2)
Withholding all DR-TB treatment for a while 13 (2.8)
Other recommendation 16 (3.4)
  1. DR-TB–drug resistant tuberculosis